These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10763448)

  • 1. IS 159.
    Drugs R D; 1999 Dec; 2(6):390-1. PubMed ID: 10763448
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 3. [Highly selective beginning. Associated symptoms and side effects in retrospect].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple-dose pharmacokinetics of intranasally administered IS-159 in healthy subjects.
    Van Giersbergen PL; Dingemanse J
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):49-54. PubMed ID: 14503664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute migraine.
    Miller FG
    Lancet; 2002 Mar; 359(9308):802. PubMed ID: 11888631
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
    Mitsikostas DD; Tfelt-Hansen P
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):241-9. PubMed ID: 22934751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
    Dahlöf CG; Falk L; Risenfors M; Lewis CP
    Cephalalgia; 1998 Oct; 18(8):546-51. PubMed ID: 9827246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.
    Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R
    Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacy-clinic medication of the month. Naratriptan (naramig)].
    Scheen AJ
    Rev Med Liege; 1999 Mar; 54(3):189-91. PubMed ID: 10321110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5HT1B/1D agonists.
    Fox AW
    J Clin Pharmacol; 2002 Nov; 42(11):1281-2; author reply 1282-3. PubMed ID: 12412829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Meta-analysis of triptan treatment in migraine].
    Nakashima K; Takeshima T; Kowa H
    No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks.
    Olesen J
    Cephalalgia; 2010 Oct; 30(10):1157-8. PubMed ID: 20855360
    [No Abstract]   [Full Text] [Related]  

  • 14. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment.
    Maggioni F; Pini LA; Zanchin G
    Cephalalgia; 2011 Jul; 31(9):1061. PubMed ID: 21511951
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of 5HT in migraine.
    Buzzi MG
    Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
    [No Abstract]   [Full Text] [Related]  

  • 17. Migraine revolution and sumatriptan.
    Palmer JB; Salonen R
    Lancet; 2000 Jun; 355(9222):2250-1. PubMed ID: 10881915
    [No Abstract]   [Full Text] [Related]  

  • 18. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
    Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.